Schedule 13G ownership disclosure

ORIC Pharmaceuticals Inc

Security class unavailable · CUSIP: 68622P109

Event date: 2023-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
2.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-24-033022
Form type
SC 13G/A
Filer
Oric Pharmaceuticals, Inc.
CIK
CIK 1796280
Filed
Feb 13, 2024
Reporting period
Dec 31, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub